Minerva Neurosciences to Present at Jefferies 2015 London Healthcare Conference on November 18, 2015
(Thomson Reuters ONE) -
WALTHAM, Mass., Nov. 13, 2015 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc.
(NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the
development of innovative therapies to treat central nervous system (CNS)
disorders, today announced that it will present at the Jefferies 2015 London
Healthcare Conference on November 18, 2015 at 9:00 a.m. Eastern Time.
The presentation will be web cast and accessible through the investor
relations section of the Company's web site,
http://ir.minervaneurosciences.com.
About Minerva Neurosciences:
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company
focused on the development and commercialization of a portfolio of products to
treat CNS diseases. Minerva's proprietary compounds include: MIN-101, in Phase
IIb development for schizophrenia; MIN-202 (JNJ-42847922), in Phase IIa and
Phase Ib development for insomnia and adjunctive major depressive disorder
(MDD), respectively; MIN-117, in Phase IIa development for MDD; and MIN-301,
in pre-clinical development for the treatment of Parkinson's
disease. Minerva's common stock is listed on the NASDAQ Global Market under
the symbol "NERV." For more information, please visit
www.minervaneurosciences.com.
CONTACT: William B. Boni
VP, Investor Relations/
Corp. Communications
Minerva Neurosciences, Inc.
(617) 600-7376
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Minerva Neurosciences, Inc. via GlobeNewswire
[HUG#1966794]
Datum: 13.11.2015 - 22:15 Uhr
Sprache: Deutsch
News-ID 434607
Anzahl Zeichen: 2115
contact information:
Town:
Waltham
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 182 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Minerva Neurosciences to Present at Jefferies 2015 London Healthcare Conference on November 18, 2015"
steht unter der journalistisch-redaktionellen Verantwortung von
Minerva Neurosciences, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
